Ion Beam Applications SA (IOBCF) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ion Beam Applications Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.857 Hello everyone and welcome to the presentation of IBA's 2025 full year results. 00:00:04.857 -- 00:00:07.680 I'm Thomas Pevenage from Investor Relations. 00:00:07.680 -- 00:00:12.486 As usual, you will find this presentation on the Investor Relations page of our website. 00:00:12.486 -- 00:00:16.190 A Q&A session will follow the formal presentation. 00:00:16.190 -- 00:00:21.096 Moving to the next page, let me draw your attention to the company's disclaimer for forward-looking 00:00:21.096 -- 00:00:25.721 statements, which as you know are based on our current assumptions and beliefs and subject 00:00:25.721 -- 00:00:28.302 to risks and uncertainties. 00:00:28.313 -- 00:00:33.640 Today's speakers are Olivier Legrain, our Chief Executive Officer and IBA Clinical 00:00:33.640 -- 00:00:39.427 Lead, Henri de Rombray, our Deputy Chief Executive Officer and IBA Technologies Lead, 00:00:39.427 -- 00:00:44.773 and Catherine Vandenborg, our Chief Financial Officer and IBA Corporate Lead. 00:00:44.773 -- 00:00:47.356 Here is the agenda for today's presentation. 00:00:47.356 -- 00:00:51.542 We will start with our highlights for the period, followed by a business review where 00:00:51.542 -- 00:00:56.647 we will discuss the strategic progress and the financials of each business unit. 00:00:56.647 -- 00:01:01.291 Finally, we will cover our financial performance in more detail and give you an update 00:01:01.291 -- 00:01:05.395 on our guidance and outlook before opening the Q&A session. 00:01:05.395 -- 00:01:09.018 Thank you, Thomas, Olivier. Good afternoon, everybody. 00:01:09.018 -- 00:01:12.441 Let me start by sharing our key messages for today. 00:01:12.441 -- 00:01:17.846 Full year 25 was a strong year for IVA. We deliver on our commitment. 0...